Center-Authored Papers

Filters: Author is Yelistratova, Lola  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2013
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
Center-Authored Paper
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
Clinical Research Division
Paulson KG, Iyer JG, Blom A, Warton ME, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM et al..  2012.  Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage.. The Journal of investigative dermatology. Abstract
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
December 2012
Paulson KG, Iyer JG, Blom A, Warton ME, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM et al..  2012.  Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage.. The Journal of investigative dermatology. Abstract
Experimental Histopathology Core Facility
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
Moshiri A, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, Delaney M, Chang O, McArdle S, Thomas H et al..  2017.  Polyomavirus-negative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multi-modal tumor virus detection.. The Journal of investigative dermatology. 137(4):819-827. Abstract
Immune Monitoring Core Facility
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
November 2013
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
Specimen Processing Core Facility
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract
Vaccine and Infectious Disease Division
Afanasiev OK, Yelistratova L, Miller N, Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM, Nghiem P.  2013.  Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(19):5351-60. Abstract